Desmopressin (dDAVP): a powerful general hemostatic agent?
Drouet
L
L
Département d'Hémostase, Hôpital Saint-Louis, Paris, France.
Scrobohaci
M L
ML
Boudaoud
S
S
Vilain
G
G
D000941:Antigens / Q000378:metabolism; D003894:Deamino Arginine Vasopressin / Q000494:pharmacology / Q000627:therapeutic use*; D004730:Endothelium, Vascular / Q000187:drug effects; D005169:Factor VIII / Q000378:metabolism; D006467:Hemophilia A / Q000188:drug therapy; D006474:Hemorrhagic Disorders / Q000188:drug therapy*; D006487:Hemostasis / Q000187:drug effects; D006488:Hemostasis, Surgical; D006490:Hemostatics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D011945:Receptors, Angiotensin / Q000187:drug effects / Q000502:physiology; D017483:Receptors, Vasopressin; D013927:Thrombosis / Q000175:diagnosis; D014841:von Willebrand Factor / Q000378:metabolism
D000941:Antigens; D006490:Hemostatics; D011945:Receptors, Angiotensin; D017483:Receptors, Vasopressin; D014841:von Willebrand Factor; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin